The Lancet Gastroenterology & Hepatology in conversation wit...

Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma

Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis

John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer

Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes

Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures

Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis

Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease

Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy

Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease

Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction

Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis

Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease

Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis

Adelina Artenie on the incidence of HIV and HCV in people who inject drugs

Johan Burisch on the costs of inflammatory bowel disease in high-income settings

Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease

Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer

Dan Turner on vedolizumab in children with IBD

Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection

James Alexander on immune responses to COVID-19 vaccination in patients with IBD

Filip Knop on liraglutide for bile acid diarrhoea

Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma

Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer

Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas

Juan Pablo Arab on NAFLD public health policies in the Americas

Sarah Blach on hepatitis C virus epidemiology

Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection

Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis

Swati Patel on early-onset colorectal cancer

Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands

Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa

Tim Vanuytsel on spore-forming probiotics in functional dyspepsia

Raymond Henderson on the economic burden of colorectal cancer

Sigurður Ólafsson on eliminating hepatitis C in Iceland

Caroline Ovadia on intrahepatic cholestasis of pregnancy

Matthew Akiyama on hepatitis C in prisons

Monika Sarkar on reproductive health in women with liver disease

Colorectal cancer risk in patients with Crohn’s disease

Liver damage in young adults

Treatments for IBS

Statins and decompensated cirrhosis

Global burden of pancreatic cancer and colorectal cancer